Adjuvant Development

Adjuvant Development is the systematic research and design of immunological enhancers that modulate and potentiate the body's adaptive immune response to vaccine antigens, distinguishing it from other vaccine components by its specific role in improving immunogenicity and vaccine efficacy.

1.7K

Publications

87.3K

Citations

9.2K

Authors

1.8K

Institutions

Publications per year

2017–2026

468

Authors

9.2K

  1. SG
    Steven G. Reed

    Infectious Disease Research Institute, United States

    29 publications · 3K citations

    26

    h-index

  2. PA
    Peter Andersen

    Statens Serum Institut, Denmark

    21 publications · 2.6K citations

    20

    h-index

  3. RN
    Rhea N. Coler

    Infectious Disease Research Institute, United States

    21 publications · 2.5K citations

    20

    h-index

  4. CB
    Christopher B. Fox

    Infectious Disease Research Institute, United States

    23 publications · 1.7K citations

    18

    h-index

  5. NP
    Nikolai Petrovsky

    Flinders University, Australia

    25 publications · 1.1K citations

    17

    h-index

1–5 of 9.2K

Venues

  1. Vaccine

    369 publications · 19.8K citations

    74

    h-index

  2. PLoS ONE

    53 publications · 3.1K citations

    31

    h-index

  3. PubMed

    Repository · 76 publications · 3.2K citations

    31

    h-index

  4. The Journal of Immunology

    JI · 38 publications · 3.8K citations

    27

    h-index

  5. Frontiers in Immunology

    47 publications · 1.4K citations

    24

    h-index

1–5